Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953194 · ClinicalTrials.gov registry record · NA
Effects of Sugary Drinks Counter-marketing Messages
A NA study of Obesity and Weight Gain, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 2,184
- Enrollment target
- 1
- Study location
NCT05953194: Completed NA study of Obesity and Weight Gain, sponsored by Stanford University.
NCT05953194 is a NA study of Obesity and Weight Gain that has completed, run by Stanford University. The registered enrollment target is 2,184 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05953194, a NA study of Obesity and Weight Gain, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,184 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to examine consumer responses to traditional and counter-marketing messages discouraging sugary drink consumption, including effects on intentions to consume sugary drinks and perceived weight stigma. Because prior research has suggested that counter-marketing may be especially effective among younger populations, the investigators will examine effects overall and by age group (young adults \[ages 18-29 years\] vs. middle and older adults \[ages 30+ years\]).
Primary Outcome
We will assess intentions to consume sugary drinks using 2 items: "In the next week, I plan to drink sugary drinks like sodas, sports drinks, or fruit drinks," and "In the next week, I am likely to drink sugar-sweetened beverages like sodas, sports drinks, or fruit drinks". Response options to both items will use a 5-point Likert scale: the first item's response options will range from "definitely not" (1) to "definitely yes" (5), and the second item's response options will range from "not at al
Conditions Studied
Interventions
- BEHAVIORAL Exposure to counter-marketing messages
- BEHAVIORAL Exposure to traditional health messages
- BEHAVIORAL Exposure to control (neutral) messages
Study Locations (1)
California
- Stanford School of Medicine - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,184 participants |
| Start Date | 2023-08-07 |
| Est. Completion | 2023-08-07 |
| Phase | NA |
What the finished NCT05953194 record still lists
NCT05953194 is an interventional study that assigns participants to a tested intervention. Its 2,184 participants enrollment target places it among the larger protocols in the corpus, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (167% higher).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Exposure to counter-marketing messages is the first listed.
NCT05953194 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05953194 about?
NCT05953194 is a clinical study titled "Effects of Sugary Drinks Counter-marketing Messages". This study aims to examine consumer responses to traditional and counter-marketing messages discouraging sugary drink consumption, including effects on intentions to consume sugary drinks and perceived weight stigma. Because prior research has suggested that counter-marketing may be especially effec...
What is the current status of trial NCT05953194?
This trial is currently completed. It is a NA study. The enrollment target is 2,184 participants. The study started on 2023-08-07. Estimated completion is 2023-08-07.
What conditions does trial NCT05953194 study?
This clinical trial studies the following conditions: Obesity, Weight Gain, Dietary Habits, Weight Prejudice.
What interventions are being tested in trial NCT05953194?
The interventions under investigation include: Exposure to counter-marketing messages (BEHAVIORAL), Exposure to traditional health messages (BEHAVIORAL), Exposure to control (neutral) messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05953194?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05953194 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05953194's enrollment target sits among peer trials
2,184 41st of 1053 higher than 1,013 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI